Latest news with #Olympus'
Yahoo
27-05-2025
- Business
- Yahoo
Olympus Announces FDA Clearance of Its Most Advanced Imaging Endoscopes
EDOF™ Technology Provides a Continuously Sharp Image with Minimal Focal Adjustment as Part of the EVIS X1™ Endoscopy System CENTER VALLEY, Pa., May 27, 2025 /PRNewswire/ -- Olympus, a global medical technology company committed to making people's lives healthier, safer and more fulfilling, announced today FDA 510(k) clearance of its EZ1500 series endoscopes featuring Extended Depth of Field (EDOF™) technology. EDOF™ endoscopes – the GIF-EZ1500 gastroscope and the CF-EZ1500DL/I colonoscope – represent Olympus' most advanced imaging and latest innovation as part of the EVIS X1™ endoscopy system. By allowing physicians to obtain sharp images, EDOF technology allows an entire lesion to be kept in focus and may aid in detection as endoscopists inspect the mucosal lining of the GI tract. EDOF technology creates an image in total focus by using two prisms to split light entering the endoscope lens into two separate beams with near- and far-focused images. Those beams are then projected simultaneously onto an image sensor, combining them into one image with a wide depth of field.1 Compared to the previous generation of Olympus® scopes, this technology provides improved visibility and less blurring. The EZ1500 series EDOF scopes allow for closer distance in normal mode compared to the CF-HQ190L/I – 3mm vs. 5mm – without blurring, limiting the need to switch from normal to near mode. The GIF-EZ1500 gastroscope and the CF-EZ1500DL/I colonoscope also feature a lightweight ErgoGrip™ control section and compatibility with Texture and Color Enhancement Imaging (TXI™), Red Dichromatic Imaging (RDI™) and Narrow Band Imaging™ (NBI™) technologies when connected to the EVIS X1 CV-1500 video system center. The ErgoGrip™ control section of EVIS X1 endoscopes is 10% lighter than the 190 series scope control section and features a rounded handle and easy-to-reach angulation control knobs and switches to accommodate users with small hands and support scope maneuverability.2 "As a leading global MedTech company, Olympus remains committed to providing advanced options to help physicians offer their patients the best care possible," said Kurt Heine, Senior Vice President and General Manager for Gastrointestinal Solutions at Olympus Corporation. "Our goal is to elevate the standard of endoscopy, and Extended Depth of Field (EDOF) technology represents Olympus' most advanced scope technology to help physicians drive the best clinical outcomes for advancing gastrointestinal procedures." The EVIS X1™ endoscopy system revolutionizes the way gastrointestinal disorders are detected, characterized and treated with innovative, easy-to-use diagnostic and therapeutic technologies and improved scope handling. The EVIS X1 endoscopy system provides a high level of patient care for every endoscopist, in every procedure, every day. In addition to the newest EDOF technology, features of the EVIS X1 endoscopy system include: TXI™ technology, which is designed to increase the visibility of lesions and polyps by enhancing image color and texture.3 RDI™ technology, which is designed to enhance the visibility of deep blood vessels and bleeding points.3 NBI™ technology, which enhances visual observation of mucosal and vascular patterns by utilizing specific blue and green wavelengths absorbed by hemoglobin.3 Brightness Adjustment Imaging with Maintenance of Contrast (BAI-MAC™) technology, which is designed to correct the brightness levels in dark areas of the endoscopic image, while maintaining the brightness of lighter areas, to increase the total distance view.4 TXI, RDI, BAI-MAC and NBI technologies are not intended to replace histopathological sampling as a means of diagnosis. These are adjunctive tools for endoscopic examination that can be used to supplement Olympus® white light imaging. Visit the EDOF product page and the EVIS X1 product page or the gastroenterology page for more information about the entire Olympus GI portfolio. About OlympusAt Olympus, we are committed to Our Purpose of making people's lives healthier, safer and more fulfilling. As a global medical technology company, we partner with healthcare professionals to provide solutions and services for early detection, diagnosis and minimally invasive treatment, aiming to improve patient outcomes by elevating the standard of care in targeted disease states. Olympus Corporation of the Americas, a wholly owned subsidiary of Olympus Corporation, is headquartered in Center Valley, Pennsylvania, USA, and employs more than 4,500 employees throughout locations in North and South America. For more information, visit 1 Data on file with Olympus (DC00493386, DC00433276, DC00510434 and DC00567392)2 Data on file with Olympus (DC00600786, DC00482729, DC00031984, DC00482747, DC00779274, DC00031984, DC00600794, DC00481878, DC00031984, DC00841888 and DC00833645)3 Data on file with Olympus (DC00489968)4 Data on file with Olympus (DC00436067) View original content to download multimedia: SOURCE Olympus Corporation of the Americas Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
19-05-2025
- Business
- Yahoo
Olympus Appoints Slawek Kierner as Chief Digital Officer
Newly created role to lead digital innovation TOKYO, May 19, 2025 /PRNewswire/ -- Olympus Corporation (Olympus), a global MedTech company committed to making people's lives healthier, safer and more fulfilling, today announced the appointment of Slawek Kierner to the role of Chief Digital Officer - Smart Connected Care (CDO-SCC), effective immediately. In this role, Slawek will report to the CTO Syed Naveed and will spearhead the integration of Olympus' medical devices with medical-assistive robot technology, digital technology, and artificial intelligence (AI). He will lead the development and expansion of Olympus' Intelligent Endoscopy Ecosystem with the OLYSENSE platform to harness digital technologies to connect legacy endoscopy devices, robotics and digital solutions. This strategic shift will enable Olympus to evolve from a hardware-centric model, characterized by longer upgrade cycles, to a dynamic model driven by continuous software enhancements, delivering "always-on" innovation. The OLYSENSE platform is a cloud-based digital endoscopy suite designed to enhance clinical and operational performance. As a leading global MedTech company, Olympus is committed to achieving efficient and optimal clinical outcomes for healthcare professionals and patients through digital technologies. "I am delighted to welcome Slawek to this pivotal role. Actively driving the digital transformation is a cornerstone of our commitment to elevating the standard of care." said Syed Naveed. "Slawek is an accomplished executive with extensive experience as a Chief Digital, Data and Analytics Officer, lecturer, advisor, investor, and board member. His more than 29 years of industry experience encompass applied artificial intelligence, digital products, and the leadership of large global technology organizations. I am confident that his profound expertise and insights will be invaluable to Olympus." Comment from Slawek Kierner"It's an honor to be appointed Chief Digital Officer – Smart Connected Care at Olympus. I am deeply passionate about the potential of digital platforms, AI and robotics to transform healthcare," said Slawek Kierner. "From real-time clinical decision support to predictive maintenance and personalized surgeon education, AI can profoundly enhance how we deliver care. I'm eager to work with Olympus's talented teams to drive meaningful impact, enhancing product intelligence, supporting surgeons, and improving outcomes for patients globally." Slawek joins Olympus from Intuitive Inc., where he served as Senior Vice President, Digital Experiences and Machine Learning Platforms since 2021. He was responsible for the company's digital products, data, and AI strategy, and he launched the AI Suite of products alongside the newest robotic platforms. He also operationally led the global Internet of Medical Things (IOMT) infrastructure, connecting more than 10,000 surgical robots, surgical simulation products, and numerous internal AI use cases. Prior to Intuitive, Slawek was Chief Data and Analytics Officer at Humana, where he led the company's transition to use cloud computing and successfully built a data and AI platform. Before Humana, he led global data analytics, applied machine learning and insights for Microsoft's Business Applications unit, including serving as a founding team member of Power BI product. Slawek holds a PhD in Clinical AI Architectures, two Master of Science degrees in Mechatronics and Management, and has attended executive education programs at Harvard Business School. He continues to reside in Boston, Mass. About OlympusAt Olympus, we are committed to Our Purpose of making people's lives healthier, safer and more fulfilling. As a global medical technology company, we partner with healthcare professionals to provide best-in-class solutions and services for early detection, diagnosis and minimally invasive treatment, aiming to improve patient outcomes by elevating the standard of care in targeted disease states. For more than 100 years, Olympus has pursued a goal of contributing to society by producing products designed with the purpose of delivering optimal outcomes for its customers around the world. For more information, visit and follow our global X account: @Olympus_Corp. View original content to download multimedia: SOURCE Olympus Corporation Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Nikkei Asia
25-04-2025
- Business
- Nikkei Asia
Japan's Olympus names ex-Medtronic exec as new CEO
TOKYO -- Japanese endoscope maker Olympus has appointed Bob White as its new CEO, the company said Friday, filling the leadership gap created by the resignation of Stefan Kaufmann over illegal drug use in October last year. White, a 62-year-old American, is a former executive at Medtronic, a U.S. medical equipment maker. "Bob possesses the skill set necessary to guide the next phase of Olympus' transformation, including quality and regulatory initiatives," the company said in a news release.
Nikkei Asia
25-04-2025
- Business
- Nikkei Asia
Japan's Olympus names Medtronic exec as new CEO
TOKYO -- Japanese endoscope maker Olympus has appointed Bob White as its new CEO, the company said Friday, filling the leadership gap created by the resignation of Stefan Kaufmann over illegal drug use in October last year. White, a 62-year-old American, is a former executive at Medtronic, a U.S. medical equipment maker. "Bob possesses the skill set necessary to guide the next phase of Olympus' transformation, including quality and regulatory initiatives," the company said in a news release.
